Updates and news related to prostate cancer:
Studying the Effects of ADT on Brain Function
An October 1, 2019 article from the Prostate Cancer Foundation
New Precision Medical Treatment Could Benefit Many Men with Treatment-Resistant Metastatic Prostate Cancer
Phase 3 clinical trial results demonstrate significant efficacy of the PARP-inhibitor for olaparib in advanced prostate cancer patients with specific tumor...
Polishing the Gold Standard in Prostate Cancer
Active surveillance has become the treatment of choice for low-risk prostate cancer, but new tools are needed to make it more...
Biomarker in Urine May Offer Non-invasive Detection of Prostate Cancer
Study reported on by a news reporter-staff news editor at Insurance Daily News
Erectile Dysfunction after Radiation for Prostate Cancer
An interview with Dr. Michael Zelefsky, a radiation oncologist at Memorial Sloan Kettering Cancer Center in New York...
Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy
Watch the video from Grand Rounds in Urology, Jackson Hole Seminars...
New Precision Medicine Treatment Could Benefit Many Men with Treatment-Resistant Metastatic Prostate Cancer
Breaking news from a study presented on October 1, 2019 at the 2019 European Society for Medical Oncology...
FDA Approves Apalutamide (Erleada) for the Treatment of Metastatic Hormone-sensitive Prostate Cancer
Read about more about this breaking news...
The Science of Living Well Beyond Cancer
Download Prostate Cancer Foundation's free guide for yourself or someone you care...
Understanding Chemo Better
Discover 6 Things You May Not Know About Chemotherapy